SEC 13F Intelligence

Natixis / LLY

Natixis’s Eli Lilly & Co Position

Does Natixis own Eli Lilly & Co (LLY)? Yes — 100.9K shares worth $93M (+0.33% of its 13F portfolio) as of Q1 2026, down from 205.0K shares the prior filed quarter.

Position Value
$93M
Q1 2026
Shares
100.9K
% of Portfolio
+0.33%
Quarters Held
27
currently held

Position History LLY

Reported value by quarter
Q3 ’19: $9MQ3 ’19Q4 ’19: $33MQ1 ’20: $2MQ2 ’20: $26MQ3 ’20: $34MQ3 ’20Q4 ’20: $62MQ1 ’21: $4MQ2 ’21: $21MQ3 ’21: $18MQ3 ’21Q4 ’21: $36MQ1 ’22: $79MQ2 ’22: $41MQ3 ’22: $110MQ3 ’22Q4 ’22: $74MQ1 ’23: $18MQ2 ’23: $164MQ3 ’23: $118MQ3 ’23Q4 ’23: $92MQ1 ’24: $172MQ2 ’24: $143MQ3 ’24: $206MQ3 ’24Q4 ’24: $107MQ1 ’25: $267MQ2 ’25: $189MQ3 ’25: $186MQ3 ’25Q4 ’25: $220MQ1 ’26: $93Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026100.9K$93M+0.33%
Q4 2025205.0K$220M+0.78%
Q3 2025244.3K$186M+0.86%
Q2 2025242.1K$189M+0.84%
Q1 2025328.5K$267M+1.46%
Q4 2024138.0K$107M+0.65%
Q3 2024232.0K$206M+1.16%
Q2 2024158.1K$143M+0.82%
Q1 2024221.5K$172M+0.90%
Q4 2023157.9K$92M+0.67%
Q3 2023220.5K$118M+0.91%
Q2 2023350.1K$164M+1.33%
Q1 202351.1K$18M+0.16%
Q4 2022203.2K$74M+0.42%
Q3 2022340.8K$110M+0.52%
Q2 2022126.1K$41M+0.15%
Q1 2022277.5K$79M+0.28%
Q4 2021130.2K$36M+0.12%
Q3 202176.9K$18M+0.06%
Q2 202193.5K$21M+0.09%
Q1 202123.0K$4M+0.01%
Q4 2020366.5K$62M+0.22%
Q3 2020228.6K$34M+0.25%
Q2 2020155.5K$26M+0.20%
Q1 202016.1K$2M+0.02%
Q4 2019251.0K$33M+0.20%
Q3 201978.9K$9M+0.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis’s full portfolio or all institutional holders of LLY.